OECD requests feedback on genetic testing QA guidelines

23 July 2006

The Organization for Economic Cooperation and Development has invited public comment and feedback regarding the new guidelines for Quality Assurance in Molecular Genetic Testing, which the body has proposed.

The document offers principles and best practice protocols for human genetic testing by encouraging high-quality laboratory research, particularly in the collection and handling of samples and data, report writing, education and training and ensuring both the clinical validity and utility of experimentation.

In addition, proposed standards are designed to encourage the use of quality assurance systems in human genetic and genomic testing, guarantee the international exchange of clinical samples, enable access to data on rare disease testing and generally help OECD member countries to supply high-quality health care.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight